Phototherapy and anti-GITR antibody-based therapy synergistically reinvigorate immunogenic cell death and reject established cancers

Qi Sun,Zhenzhen Yang,Meng Lin,Yiwei Peng,Rudong Wang,Yitian Du,Yu Zhou,Jiajia Li,Xianrong Qi

DOI: https://doi.org/10.1016/j.biomaterials.2020.120648

IF: 14

2021-02-01

Biomaterials

Abstract:<p>Phototherapy and immunogenic cell death (ICD) are powerful strategies to fight cancer. However, their therapeutic outcomes are diminished by immunosuppressive and hypoxia microenvironment. Herein, a photo-based, immunomodulating and hypoxia-alleviated nanosystem, , is proposed to achieve the synergism between phototherapy and immunotherapy. Catalase (CAT) and anti-GITR antibody (DTA-1) are loaded to photothermal agent and photosensitizer composed PDA-ICG nanoparticles. The exhibits intrinsic local hyperthermia and enhanced ROS generation in tumor and abrogates tumor immune suppression. It results in reduction of intratumoral FOXP3⁺ regulatory T cells (4.3-fold) and increase of CD4⁺ effector T cells (1.5-fold) compare with the control, and promoting damage associated molecular patterns generation to reinvigorate ICD effect. The potent antitumor of is proved in 4T1 bilateral tumor-bearing mice, with inhibition ratio of 95.1% for primary cancers and 68.7% for abscopal cancers. Our findings highlight great promise of the constructed versatility nanosystem to fix bottlenecks for cancer therapy.</p>

engineering, biomedical,materials science, biomaterials